益气养阴汤辅助达格列净、二甲双胍治疗2型糖尿病患者的临床疗效及对血管内皮功能的影响

doi:10.3969/j.issn.1671-7171.2025.08.016

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (1283 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To explore the clinical efficacy of Yiqi Yangyin Decoction assisted with dapagliflozin and metformin in the treatment of patients with type 2 diabetes mellitus (T2DM) and its impact on vascular endothelial function. 【Methods】A total of 94 T2DM patients admitted to Fangcheng County Hospital of Traditional Chinese Medicine from February 2022 to February 2024 were selected and divided into an observation group and a control group by coin toss method, with 47 cases in each group. The control group received conventional treatment with dapagliflozin and metformin, while the observation group was given additional Yiqi Yangyin Decoction on the basis of the control group. The blood glucose indicators [fasting plasma glucose (FPG), glycated hemoglobin (HbA1c), 2-hour postprandial blood glucose (2hPG)], TCM syndrome scores, vascular endothelial function indicators [adiponectin (ADPN), nitric oxide (NO), endothelin (ET)], and the occurrence of adverse reactions were compared between the two groups. 【Results】After treatment, the levels of FPG, HbA1c, 2hPG, ET and TCM syndrome scores in the observation group were lower than those in the control group (P<0.05), while the levels of ADPN and NO were higher than those in the control group (P<0.05). The total incidence of adverse reactions in the observation group was lower than that in the control group (P<0.05).【Conclusion】Yiqi Yangyin Decoction assisted with dapagliflozin and metformin can effectively improve the blood glucose level and vascular endothelial function of T2DM patients, reduce the incidence of adverse reactions, improve the TCM syndrome score, and has high safety.

Key words： Diabetes Mellitus, Type 2 Metformin Integrated Chinese Traditional and Western Medicine Therapy Endothelium, Vascular Treatment Outcome

Received: 15 April 2025

PACS:

R587.1

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LIU Shiwei
	PANG Jianguo
	ZHANG Lingguo

Cite this article:

LIU Shiwei,PANG Jianguo,ZHANG Lingguo. Clinical Efficacy of Yiqi Yangyin Decoction Assisted with Dapagliflozin and Metformin in the Treatment of Patients with Type 2 Diabetes Mellitus and its Impact on Vascular Endothelial Function[J]. JOURNAL OF CLINICAL RESEARCH, 2025, 42(8): 1350-1352.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2025.08.016 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2025/V42/I8/1350

[1] 冯静,杜文森. 参麦益气养阴汤加减联合格列齐特缓释片治疗2型糖尿病的研究[J].中医研究,2024,37(5):54-58.
[2] 张智珍,罗文娟,范燕,等. 益气养阴消癥通络汤治疗早期糖尿病肾病的临床效果[J].中国实用医药,2024,19(6):149-152.
[3] 韩治华,王菊宁,魏文娟,等. 自拟益气养阴汤治疗2型糖尿病相关干眼的疗效观察[J].中国中医眼科杂志,2021,31(12):873-877.
[4] 孙晓娟,闫亮. 益气养阴活血汤联合二甲双胍治疗2型糖尿病临床研究[J].新中医,2021,53(9):62-64.
[5] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华糖尿病杂志,2021,13(4):315-409.
[6] 全小林.糖尿病中医药临床循证实践指南(2016版)[M].北京:科学出版社,2016:56-57.
[7] 王平,王芳,左新河. 增液汤合六磨汤加减对糖尿病合并便秘患者血清5-HT、胃动素、血管活性肠肽水平的影响[J].辽宁中医杂志,2024,51(5):131-135.
[8] 蒋琰瑜,骆雨,廖彩云,等. 大黄黄连泻心汤联合针刺治疗肥胖2型糖尿病患者的临床研究[J].检验医学与临床,2024,21(14):2001-2005.
[9] 朱德礼,张宇,张元丽,等. 参麦地黄汤联合坎地沙坦酯治疗早期糖尿病肾病疗效及对患者血清转化生长因子-β1、单核细胞趋化蛋白-1的影响[J].陕西中医,2023,44(2):209-212.
[10] 吴攀峰,张淑娟. 参麦益气养阴汤联合西药治疗糖尿病气阴两虚证的疗效观察[J].中国中医药科技,2022,29(3):487-489.
[11] 申子龙,杜泳霖,赵文景. 基于文献探讨2型糖尿病肾脏病Ⅳ期中医辨治规律[J].国际中医中药杂志,2023,45(8):1044-1048.
[12] 陈先乐,章春花. 达格列净联合盐酸二甲双胍治疗2型糖尿病患者的临床疗效[J].医学临床研究,2024,41(3):434-437.
[13] 李文飞,章凯文,谢鸣. 中医治疗2型糖尿病组方用药经验的数据挖掘[J].中国药师,2021,24(10):1889-1894.
[14] 马宁宁,李锐,何娟,等. 益气养阴汤联合西医常规治疗对初治2型糖尿病患者症状改善、糖脂代谢、胰岛素相关因子的影响[J].广西医学,2020,42(17):2219-2222.
[15] 汤超,王露. 益气养阴汤加减联合达格列净、二甲双胍对初诊2型糖尿病患者的疗效及血压、血尿酸水平的影响[J].中医药学报,2024,52(7):76-80.